TP53 and skin basal cell carcinoma: Sixty of the 191 (31%) BCC carried alterations in TP53, with 31 (16%) tumors carrying more than one mutation; 24 tumors carried two mutations and 4 tumors carried three mutations and 3 tumors carried four mutations.